New blinded data from ~45 patients to date in key pain and function scales and safety and tolerability of the Company’s proprietary hypoxic-cultured mesenchymal stem cells to be unveiled on March 28th ...
Longeveron Inc. (NASDAQ:LGVN) Q4 2025 Earnings Call Transcript March 17, 2026 Longeveron Inc. beats earnings expectations.
Joining me on today’s call are Sean Nolan, Taysha Gene Therapies, Inc.'s Chief Executive Officer; Sukumar Nagendran, ...
Download Executive Order No. 15ESTABLISHING THE OFFICE OF COMMUNITY SAFETYWHEREAS, the City of New York currently offers programs that address issues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results